Siemens Healthineers Summer Forum on COVID-19 TestingLeading the Way to Normalcy

Dates: Sessions are available on demand when you register

Location: Online

Please visit our virtual exhibitor area during the course of the congress and join our summer forum.

Siemens Healthineers Summer Forum on COVID-19 Testing

Changing COVID-19 testing demands require clinical laboratories to keep up with an increasing number of patients, samples, and variants. Siemens Healthineers provides the flexibility you want for the clinical results you need with innovative, COVID-19 testing solutions.

While at the Siemens Healthineers Summer Forum, attend our live presentations, meet our experts, and explore our COVID-19 testing portfolio, from a highly sensitive RT-PCR test to high throughput or point of care antigen and antibody assays.

View our expert presentations information here! (pdf) 0.3 MB

Our Products

30th ECCMID<br />18 – 21 April 2020 Paris, France<br />Paris Convention Centre<br />Pavilion 7<br />Place de la Porte de Versailles<br />75015 Paris, France<br /><br />Siemens Healthineers booth #181

At the Summer Forum on COVID-19 Testing, you will learn how Siemens Healthineers is shaping the future of healthcare, so you can drive better outcomes.

From the lab to the point of care, Siemens Healthineers offers a full portfolio of COVID-19 testing solutions that consistently delivers sensitivity and performance—to get us to what’s next.

Large-scale Testing and Diagnosis

Clinicians use diagnostic tests to determine if people have current COVID-19 infections, enabling patient management decisions.

High-throughput Lab Antigen Testing

Intended for fast, safe and accurate, high-scale community screening.

SARS-CoV-2 Antigen Assay²

Molecular PCR Testing

Gold standard for accurate and early detection of infection.

FTD SARS-CoV-2 Assay³

Satellite Testing

Near-patient testing can be used to identify and isolate infected people more quickly.

Point-of-care Rapid Antigen Testing

Rapid antigen testing can help communities get ahead of the spread.

CLINITEST^® Rapid COVID-19 Antigen Test¹

Management and Monitoring

Management and monitoring are critical in determining the full scope of the disease, combating the pandemic, and rebuilding public conﬁdence.

High-throughput Lab Antibody Testing

Highly accurate for detection and monitoring of immune response through infection and in vaccination.

Point-of-care Antibody Testing

Our Booth

How can your laboratory deliver more impactful results for the detection and management of COVID-19?

Explore Siemens Healthineers full portfolio of COVID-19 testing solutions that consistently delivers sensitivity and performance—to get us to what’s next on the path to normalcy.

View our expert presentations information here! (pdf) 0.3 MB

Did this information help you?

Distributed by Siemens Healthineers. CLINITEST Rapid COVID-19 Antigen Test: Not available for sale in the U.S.

This test has not been reviewed by the FDA. In the U.S., use of this test is limited to laboratories that are certiﬁed under Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high-complexity testing.

The SARS-CoV-2 molecular and antibody tests have not been FDA-cleared or approved. These tests have been authorized by FDA under an EUA for use by authorized laboratories. The molecular test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The antibody test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. These tests are only authorized. for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the. authorization is terminated or revoked sooner. Product availability may vary from country to country and is subject to varying regulatory requirements.